Revvity ($RVTY) Stock Forecast: Up 3.0% Today

What is Revvity?

Revvity (RVTY) is a company operating in the diagnostics and life sciences sectors. The stock had a strong bullish movement today.

Why is Revvity going up?

RVTY stock is up 3.0% on Nov 4, 2024 15:40

• RVTY surpassed Q3 earnings and revenue estimates, showing strong financial performance.
• The positive earnings surprise hints at solid performance in the Diagnostics segment.
• Despite facing challenges in the Life Sciences segment, the overall performance exceeded expectations, prompting the stock's bullish movement.
• Investor confidence in the company's future likely increased following the Q3 results.

RVTY Price Chart

RVTY Technical Analysis

RVTY News

Revvity ( RVTY ) Surpasses Q3 Earnings and Revenue Estimates

Revvity (RVTY) delivered earnings and revenue surprises of 13.27% and 0.95%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2363024/revvity-rvty-surpasses-q3-earnings-and-revenue-estimates

Revvity to Report Q3 Earnings: What's in Store for the Stock?

RVTY third-quarter results are likely to reflect decent performance in the Diagnostics segment, while the Life Sciences segment is likely to face continued challenges in China.

https://www.zacks.com/stock/news/2362850/revvity-to-report-q3-earnings-whats-in-store-for-the-stock

Trending Today

Fetch.ai ($FET) Crypto Forecast: Up 5.4% Today

Shiba Inu ($SHIB) Crypto Forecast: Up 5.1% Today

Dogecoin ($DOGE) Crypto Forecast: Up 8.4% Today

THORChain ($RUNE) Crypto Forecast: Down 9.6% Today

Bonk ($BONK) Crypto Forecast: Up 5.1% Today

Toncoin ($TON) Crypto Forecast: Down 5.0% Today

Celestia ($TIA) Crypto Forecast: Down 6.1% Today

Natural Gas ($GAS) Commodity Forecast: Up 5.3% Today

Pendle ($PENDLE) Crypto Forecast: Down 7.2% Today

Memecoin ($MEME) Crypto Forecast: Down 5.9% Today

Revvity Price History

14.10.2023 - RVTY Stock was up 5.0%

• The investigation by Pomerantz LLP might have caused some uncertainty among investors, but it did not have a significant impact on the stock's bullish movement.
• Other positive factors, such as strong financial performance or favorable market conditions, likely contributed to the bullish movement of RVTY.
• Investors may have been optimistic about the future prospects of Revvity, Inc., leading to increased buying interest and driving the stock price higher.
• It is important to monitor any developments related to the investigation by Pomerantz LLP to assess any potential impact on the stock in the future.

04.10.2024 - RVTY Stock was up 3.0%

• RVTY surpassed Q3 earnings and revenue estimates, showing strong financial performance.
• The positive earnings surprise hints at solid performance in the Diagnostics segment.
• Despite facing challenges in the Life Sciences segment, the overall performance exceeded expectations, prompting the stock's bullish movement.
• Investor confidence in the company's future likely increased following the Q3 results.

13.01.2024 - RVTY Stock was down 5.0%

• The recent introduction of Revvity's clinical data science platform may not have a direct connection to RVTY's decline in the market.
• Various other factors, including weak financial performance or unfavorable market sentiment, could have played a role in the stock's downward trend.
• It is crucial to take into account any other developments or occurrences that might have impacted RVTY's bearish movement.

31.09.2023 - RVTY Stock was down 8.4%

• Revvity's Q3 report and lowered forecast contributed to the bearish movement in its stock.
• The company's earnings and sales missed estimates, reflecting the impact of increased market uncertainty.
• The demand from its pharma and biotech customers fell, further adding to the negative sentiment.
• The disappointing performance of Revvity also had a spillover effect on other life science tool providers, dragging down their stocks as well.

25.09.2023 - RVTY Stock was down 5.1%

• The decline in earnings is likely a significant factor contributing to the bearish movement of Revvity's stock today.
• The lack of a positive earnings beat expectation may have disappointed investors and led to selling pressure on the stock.
• The new partnership announcement, although positive for the long-term prospects of the company, may not have been enough to offset the negative sentiment surrounding the earnings decline.

03.10.2023 - RVTY Stock was up 5.3%

• Revvity's disappointing Q3 report and lowered forecast initially caused a plunge in the stock, but it managed to recover and have a bullish movement.
• The company's earnings and sales missed estimates, reflecting the impact of increased market uncertainty.
• Despite the negative news, some articles suggest that Revvity is an undervalued gem in the medical diagnostics and research industry.
• Other life science tool providers may have been affected by Revvity's performance, leading to a broader bearish sentiment in the industry.

30.09.2023 - RVTY Stock was down 4.6%

• Revvity reported Q3 financial results that missed both top and bottom line estimates, with a lower-than-expected Non-GAAP EPS of $1.18 and a revenue of $670.74M (-5.8% Y/Y).
• The company's GAAP earnings per share for the quarter were $0.08, compared to $0.67 in the same period last year, and GAAP revenue decreased from $712 million to $671 million year-over-year.
• Analysts had estimated an EPS of $1.19 and a revenue of $694.52M for the quarter, which were not met by Revvity.
• Additionally, Revvity declared a quarterly dividend of $0.07 per share, which may have influenced investor sentiment.
• Overall, Revvity's weaker-than-expected financial results and missed estimates likely contributed to the bearish movement of the stock today.

11.06.2024 - RVTY Stock was up 6.2%

• Investors are displaying confidence in Revvity, Inc. prior to its earnings call, indicating high hopes for favorable financial outcomes.
• The upcoming executive conference call demonstrates a commitment to transparency and proactive communication with shareholders, likely enhancing investor trust.
• The upward movement in the stock price may be attributed to expectations of strong performance in the second quarter, potentially driven by effective business strategies or initiatives for revenue growth.